High-Fermented Food Intervention Among Locally Advanced Rectal Cancer Patients (The FEED Trial) - Trial NCT06337552
Access comprehensive clinical trial information for NCT06337552 through Pure Global AI's free database. This phase not specified trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute and is currently Recruiting. The study focuses on Rectal Cancer. Target enrollment is 30 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
H. Lee Moffitt Cancer Center and Research Institute
Timeline & Enrollment
N/A
Feb 19, 2024
Mar 01, 2027
Primary Outcome
Effects of the FEED-FF diet on clinical response to chemoradiation,Effects of FEED-FF diet on the gut microbiome,Effects of FEED-FF diet on local immune-related biomarkers,Effects of FEED-FF diet on quality of life,Efficacy of the FEED-FF intervention,Feasibility of the FEED-FF intervention
Summary
The purpose of the study is to evaluate the feasibility and acceptability of a dietary
 intervention (FEED-FF) that includes fermented foods (FF), among locally advanced rectal
 cancer patients, and to explore whether this diet can improve outcomes in rectal cancer
 patients receiving chemoradiotherapy (CRT).
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06337552
Non-Device Trial